Heron Therapeutics Inc (NASDAQ:HRTX)

19.38
Delayed Data
As of Aug 26
 +0.11 / +0.57%
Today’s Change
15.22
Today|||52-Week Range
42.25
-27.42%
Year-to-Date

Today’s Trading

Previous close19.27
Today’s open19.24
Day’s range19.15 - 19.99
Volume358,334
Average volume (3 months)633,507
Market cap$752.5M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-2.79%
Earnings growth (this year)-48.90%
Earnings growth (next 5 years)+70.57%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.89

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...+0.31+7.08%
SGNTSagent Pharmaceutica...0.000.00%
INSMInsmed Inc+0.32+2.48%
ZIOPZIOPHARM Oncology In...+0.09+1.74%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$1.15
Annual revenue (last year)$0.00
Annual profit (last year)-$97.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers

NextAdvisor